Morgan Stanley Upgrades Core Laboratories (CLB) to Overweight

Morgan Stanley analyst Connor Lynagh upgraded Core Laboratories (NYSE: CLB) from Equalweight to Overweight.

For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on Core Laboratories click here.

Shares of Core Laboratories closed at $18.59 yesterday.

You May Also Be Interested In

• Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO
• Johnson & Johnson upgraded to Buy at HSBC on 'asymmetric risk and attractive upside'
• RBC Capital Upgrades EDP Renovaveis SA (EDPR:LI) (EDRVF) to Outperform